title: [Cytologic observations of cervicovaginal smears during hormonal contraception].
authors.forename: P
authors.initials: P
authors.lastname: Ide
authors.forename: P
authors.initials: P
authors.lastname: Wijnants
authors.forename: J
authors.initials: J
authors.lastname: Bonte
mesh_terms: D000367:Age Factors; D001530:Belgium; D001695:Biology; D001723:Birth Rate; D002477:Cells; D002584:Cervix Uteri; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003710:Demography; D019049:Developed Countries; D004194:Disease; D005060:Europe; D005193:Family Planning Services; D005298:Fertility; D005835:Genitalia; D005836:Genitalia, Female; D008234:Lynestrenol; D017258:Medroxyprogesterone Acetate; D008656:Mestranol; D009369:Neoplasms; D010298:Parity; D010827:Physiology; D011153:Population; D011154:Population Characteristics; D011157:Population Dynamics; D011446:Prospective Studies; D012106:Research; D014566:Urogenital System; D002583:Uterine Cervical Neoplasms; D014599:Uterus; D014621:Vagina; D014627:Vaginitis
chemical_list: D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D008656:Mestranol; D017258:Medroxyprogesterone Acetate; D008234:Lynestrenol
keywords: Age Factors; Belgium; Biology; Cancer; Cervical Cancer; Cervical Effects; Cervix; Clinical Research; Contraception; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Cytologic Effects; Demographic Factors; Developed Countries; Diseases; Europe; Family Planning; Fertility; Fertility Measurements; Genitalia; Genitalia, Female; Lynestrenol--side effects; Medroxyprogesterone Acetate--side effects; Mestranol--side effects; Neoplasms; Oral Contraceptives; Oral Contraceptives, Combined; Oral Contraceptives, Phasic; Parity; Physiology; Population; Population Characteristics; Population Dynamics; Prospective Studies; Research Methodology; Studies; Urogenital System; Uterus; Vaginal Abnormalities; Vaginal Desquamate Effects; Vaginitis; Western Europe